Statistics from Altmetric.com
During the last fifteen years, numerous peer-reviewed journals published articles about the incredible properties of so-called release-active “drugs” (RADs).1–24 It is claimed that these “drugs” are effective against tick-borne encephalitis, influenza, hemorrhagic fever with renal syndrome, meningococcal meningitis, herpes, HIV, and other viral and bacterial infections, diabetes, erectile dysfunction, sleep disorders, obesity, chronic inflammatory joint diseases, attention deficit hyperactivity disorder, chronic cerebral ischemia, benign prostatic hypertrophy, alcoholism, allergies, and many other health problems.18 25 In addition, it was publicly announced that they would provide new opportunities to overcome antibiotic resistance and significantly improve the prospects for the treatment of certain forms of cerebral palsy, schizophrenia, and stroke.26 Surprisingly, these innovative “drugs” contain no active molecules and can be considered a new brand of homeopathy. This indicates one of two possibilities: either we are at the brink of a revolution in medicine or that something went wrong with research published in numerous academic journals. We argue that the latter explanation is more likely and that this conclusion has severe implications for the scientific and healthcare enterprises.
Release-activity as disguised homeopathy
Release-active ‘drugs’ (RADs)1–24 are manufactured by a single Russian company called OOO ‘NPF ‘Materia Medica Holding’ (MMH).25 26 According to the original patent by its founder and CEO Epstein et al,27 these preparations consist of ‘activated forms of ultra-low doses of antibodies conventionally designated as potentiated (dynamised) antibodies (by analogy with the terminology used in homeopathic literature) for treatment of various pathological syndromes’. The problem is that typical dilutions of the active ingredient are so high (from 1:1024 to 1:101991) that no molecules of the initial antibodies should be present in the ‘drug’ itself. The inventors claim that although the ‘drugs’ activity ‘originates from the initial substance, it does not depend on its negligible …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.